1. Home
  2. ATLX vs CRDL Comparison

ATLX vs CRDL Comparison

Compare ATLX & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLX
  • CRDL
  • Stock Information
  • Founded
  • ATLX 2011
  • CRDL 2017
  • Country
  • ATLX Brazil
  • CRDL Canada
  • Employees
  • ATLX N/A
  • CRDL N/A
  • Industry
  • ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATLX Industrials
  • CRDL Health Care
  • Exchange
  • ATLX Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • ATLX 101.9M
  • CRDL 104.5M
  • IPO Year
  • ATLX N/A
  • CRDL N/A
  • Fundamental
  • Price
  • ATLX $6.90
  • CRDL $1.21
  • Analyst Decision
  • ATLX Strong Buy
  • CRDL Strong Buy
  • Analyst Count
  • ATLX 3
  • CRDL 3
  • Target Price
  • ATLX $33.17
  • CRDL $9.00
  • AVG Volume (30 Days)
  • ATLX 85.6K
  • CRDL 313.1K
  • Earning Date
  • ATLX 11-08-2024
  • CRDL 11-14-2024
  • Dividend Yield
  • ATLX N/A
  • CRDL N/A
  • EPS Growth
  • ATLX N/A
  • CRDL N/A
  • EPS
  • ATLX N/A
  • CRDL N/A
  • Revenue
  • ATLX $543,657.00
  • CRDL N/A
  • Revenue This Year
  • ATLX N/A
  • CRDL N/A
  • Revenue Next Year
  • ATLX $8,777.97
  • CRDL N/A
  • P/E Ratio
  • ATLX N/A
  • CRDL N/A
  • Revenue Growth
  • ATLX N/A
  • CRDL N/A
  • 52 Week Low
  • ATLX $6.12
  • CRDL $0.96
  • 52 Week High
  • ATLX $26.24
  • CRDL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • ATLX 48.46
  • CRDL 32.75
  • Support Level
  • ATLX $6.80
  • CRDL $1.17
  • Resistance Level
  • ATLX $7.25
  • CRDL $1.30
  • Average True Range (ATR)
  • ATLX 0.45
  • CRDL 0.08
  • MACD
  • ATLX 0.05
  • CRDL 0.00
  • Stochastic Oscillator
  • ATLX 37.23
  • CRDL 11.76

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. They intend to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: